|
|
|
|
| LEADER |
007700000a22002530004500 |
| 020 |
|
|
|a 1-57491-120-1
|
| 082 |
|
|
|a 615.1 P81
|
| 100 |
|
|
|a Gibson, Mark; Editor
|
| 245 |
|
|
|a Pharmaceutical preformulation and formulation
|
| 250 |
|
|
|
| 260 |
|
|
|a London, CRC Press
|
| 260 |
|
|
|c 2008
|
| 460 |
|
|
|a xi, 596p
|
| 465 |
|
|
|a Rs. 0.00
|
| 500 |
|
|
|a ed by Mark Gibson
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 650 |
|
|
|a Dosage forms
|
| 650 |
|
|
|a Drug compounding
|
| 650 |
|
|
|a Drug Discovery
|
| 650 |
|
|
|a Drug evaluation
|
| 650 |
|
|
|a Drugs-Dosage forms
|
| 942 |
|
|
|c BK
|
| 999 |
|
|
|c 47690
|d 47690
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_P81
|7 0
|8 ENG
|9 48422
|a MGUL
|b MGUL
|d 2013-07-16
|e Rs. 0.00
|l 13
|m 13
|o 615.1 P81
|p 45944
|r 2020-09-16
|s 2020-06-24
|w 2013-07-16
|y BK
|